Related Experiment Videos
Comparing clock tests for dementia screening: naïve judgments vs formal systems--what is optimal?
James M Scanlan1, Michael Brush, Christina Quijano
1Alzheimer's Disease Research Center, University of Washington, Seattle 98195-6560, USA. jscanlan@u.washington.edu
International Journal of Geriatric Psychiatry
|January 22, 2002
Summary
Clock drawing tests (CDTs) effectively screen for dementia, with the Mendez and CERAD systems showing high accuracy. Untrained raters also performed well, suggesting CDTs improve dementia recognition.
Area of Science:
- Neurology
- Geriatrics
- Cognitive Assessment
Background:
- Clock drawing tests (CDTs) are used for dementia screening but vary in format, scoring, and complexity.
- This study compared the dementia screening performance of seven CDT scoring systems and untrained raters.
Purpose of the Study:
- To evaluate and compare the diagnostic accuracy of different Clock Drawing Test scoring systems.
- To assess the effectiveness of untrained raters in identifying dementia using CDTs.
- To determine if CDTs improve upon existing methods for dementia recognition, particularly for mild cases.
Main Methods:
- 80 clock drawings from subjects with known dementia status (normal, mild, moderate, severe) were analyzed.
- An expert scored clocks using seven established CDT scoring systems.
- 20 untrained raters judged clocks as normal or abnormal without formal scoring criteria.
Main Results:
- Formal CDT systems and untrained raters showed high agreement (90-100%) for normal, moderate, and severe dementia, but poor agreement for mild impairment (39%).
- The Mendez and CERAD systems demonstrated the highest accuracy in classifying dementia (84-85%).
- Untrained raters' judgments were as effective as five of the seven formal CDT systems.
Conclusions:
- The Mendez CDT system was the most accurate overall, though not significantly superior to the simpler CERAD system.
- Untrained raters demonstrated acceptable accuracy for community-based dementia screening.
- CDTs, particularly when used by physicians, can enhance the detection of mild dementia.